Gender Justice Responds to Medication Abortion Decision by U.S. Supreme Court
Friday, April 21, 2023
The following statement can be attributed to Gender Justice Executive Director Megan Peterson:
While we are relieved that the Supreme Court pressed pause on the lower courts’ dangerous overreach for now, the fact remains that it should never have gotten here in the first place. With the stroke of a pen, a single anti-abortion district court judge in Texas jeopardized the ability of people across the country – including here in Minnesota – to access mifepristone, a safe and effective medication and the standard of care for medication abortion. Luckily, access to Mifepristone remains unchanged today. But as this case continues, we will be watching its developments and impact on health care closely.